Mortality Risk Factors for Patients with Septic Shock after Implementation of the Surviving Sepsis Campaign Bundles

다국어 초록 (Multilingual Abstract)

Background: Septic shock remains a leading cause of death, despite advances in critical care management. The Surviving Sepsis Campaign (SSC) has reduced morbidity and mortality. This study evaluated risk factors for mortality in patients with septic shock who received treatment following the SSC bundles.
Materials and Methods: This retrospective cohort study included patients with septic shock who received treatments following SSC bundles in an urban emergency department between November 2007 and November 2011. Primary and secondary endpoints were all-cause 7- and 28-day mortality.
Results: Among 436 patients, 7- and 28-day mortality rates were 7.11% (31/436) and 14% (61/436), respectively. In multivariate analysis, high lactate level (odds ratio [OR], 1.286; 95% confidence interval [CI], 1.016-1.627; P = 0.036) and low estimated glomerular filtration rate (OR, 0.953; 95% CI, 0.913-0.996; P = 0.032) were independent risk factors for 7-day mortality. Risk factors for 28-day mortality were high lactate level (OR, 1.346; 95% CI, 1.083-1.673; P = 0.008) and high Acute Physiology and Chronic Health Evaluation II score (OR, 1.153; 95% CI, 1.029-1.293; P = 0.014).
Conclusion: The risk of mortality of septic shock patients remains high in patients with high lactate levels and acute kidney injury.

참고문헌 (Reference)

1 Mouncey PR, "Trial of early, goal-directed resuscitation for septic shock" 372 : 1301-1311, 2015

2 Vincent JL, "The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine" 22 : 707-710, 1996

3 Bernard GR, "The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination" 149 : 818-824, 1994

4 Dellinger RP, "Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock, 2012" 39 : 165-228, 2013

5 Dellinger RP, "Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008" 34 : 17-60, 2008

6 Bakker J, "Serial blood lactate levels can predict the development of multiple organ failure following septic shock" 171 : 221-226, 1996

7 Drumheller BC, "Risk factors for mortality despite early protocolized resuscitation for severe sepsis and septic shock in the emergency department" 31 : 13-20, 2016

8 Park DW, "Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock: a propensity-matched analysis" 40 : 3140-3145, 2012

9 Dupont H, "Outcome of postoperative pneumonia in the Eole study" 29 : 179-188, 2003

10 Nguyen HB, "Outcome effectiveness of the severe sepsis resuscitation bundle with addition of lactate clearance as a bundle item: a multi-national evaluation" 15 : R229-, 2011

11 Puskarich MA, "One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study" 13 : R167-, 2009

12 Harbarth S, "Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis" 115 : 529-535, 2003

13 Na S, "Implementation of early goal-directed therapy and the surviving sepsis campaign resuscitation bundle in Asia" 24 : 452-462, 2012

14 ARISE Investigators, "Goal-directed resuscitation for patients with early septic shock" 371 : 1496-1506, 2014

15 박대원, "Epidemiological and Clinical Characteristics of Community- Acquired Severe Sepsis and Septic Shock: A Prospective Observational Study in 12 University Hospitals in Korea" 대한의학회 27 (27): 1308-1314, 2012

16 Rivers EP, "Early interventions in severe sepsis and septic shock: a review of the evidence one decade later" 78 : 712-724, 2012

17 Focht A, "Early goal-directed therapy: improving mortality and morbidity of sepsis in the emergency department" 35 : 186-191, 2009

18 Rivers E, "Early goal-directed therapy in the treatment of severe sepsis and septic shock" 345 : 1368-1377, 2001

19 Bone RC, "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine" 101 : 1644-1655, 1992

20 Murphy SL, "Deaths: preliminary data for 2010" 60 : 1-51, 2012

21 Garner JS, "CDC definitions for nosocomial infections, 1988" 16 : 128-140, 1988

22 de Mendonça A, "Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score" 26 : 915-921, 2000

23 Uchino S, "Acute renal failure in critically ill patients: a multinational, multicenter study" 294 : 813-818, 2005

24 Knaus WA, "APACHE II: a severity of disease classification system" 13 : 818-829, 1985

25 ProCESS Investigators, "A randomized trial of protocol-based care for early septic shock" 370 : 1683-1693, 2014

26 Ho KM, "A comparison of admission and worst 24-hour Acute Physiology and Chronic Health Evaluation II scores in predicting hospital mortality: a retrospective cohort study" 10 : R4-, 2006

27 Hughes WT, "2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer" 34 : 730-751, 2002